ERBB2 and breast carcinoma: For the Clinical model, microcalcifications and aspect ratios were important features in predicting HER2 status, and HER2-positive breast cancers were more likely to show intralesional microcalcifications and growth perpendicular to the skin, as shown in Fig. 7A–C.